Description
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Recruitment for_this Trial is Closed to Accrual
This trial is available at multiple Sutter Locations. Please contact one of the following about Study Alliance A011401
San Francisco: ClinicalResearch@sutterhealth.org
Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
East Bay: Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: Isabel Rodrigues-Fong Rodrigi@sutterhealth.org and Kirsten Babski babskik@sutterhealth.org
Modesto: Adrienne Palos PalosA@sutterhealth.org
Solano-Vallejo Cancer Center: Stephanie Gonzales gonzals1@sutterhealth.org
San Mateo: Stephanie Casal CasalSL@sutterhealth.org and Bonnie Chan ChanBW@sutterhealth.org
Santa Rosa: Patricia Grinnell GrinneP@sutterhealth.org and Mohammad Naseem NaseemMK@sutterhealth.org
View study details on ClinicalTrials.gov
Principal Investigator
Oleg I. Krijanovski, M.D., Ph.D.
Recruitment Status
Active, Not Recruiting
Please note that trial statuses change frequently,
for the most up to date information regarding REDI's enrolling studies; please
contact the research department at 510-204-4155.
Funder
Alliance for Clinical Trials Oncology
Start Date
February 16, 2017
Related Studies
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.